Program Schedule

New Issues in HIV-Related Opportunistic Infection Management

Saturday, October 11, 2014: 2:00 PM-3:30 PM
Room: The Pennsylvania Convention Center: 118-ABC

Learning Objectives:

At the conclusion of this session, particpants will be able to:

  • describe pro's and con's of new/novel agents in the pipeline for treatment of TB
  • describe the appropriate use of point-of-care diagnostic tests in the diagnosis of opportunistic infections in HIV
  • outline strategies to use the principles related to the management of Cryptococcal disease in HIV in their own practice

Target Audience: Researchers, Public health practitioners, Nurses, Members-in-training, Infectious diseases physicians, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Health care workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: HIV-STD-TB

2:00 PM
New TB Drugs in the Pipeline
Eric Nuermberger, MD
3:00 PM
Update on Cryptococcal Meningitis Management
A. Tariro Makadzange, MD DPhil

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-147-L02-P


E. Nuermberger, Global Alliance for TB Drug Development: Grant Investigator, Research grant
Sequella: Collaborator, Licensing agreement or royalty and Research support

Y. Manabe, None

A. T. Makadzange, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek